Bremelanotide — FDA-approved melanocortin agonist for female sexual dysfunction. Acts via CNS, not vascular like PDE5 inhibitors.
FDA approval: Vyleesi — FDA-approved (HSDD female sexual signaling)
Central: Acts in hypothalamus via MC4R — not vasodilator
Both sexes: Activity reported in both sexes — research area: melanocortin sexual signaling pathway
$109 USD
💰 Buy multiple and save: 3+ vials −5% · 5+ −10%
📋 Technical datasheet · Compound specifications
Compound
PT-141 Bremelanotide
Origin
🇺🇸 Lyophilized in USA (US-based facilities)
Form
Lyophilized in sterile vial (or pre-mixed solution depending on SKU)
Molecular formula
C50H68N14O10
Molecular weight
1025.18 g/mol
Purity
≥99% by HPLC + mass spectrometry (Janoshik Analytical)
Storage
Lyophilized: −20°C to −80°C, dry, dark · Reconstituted: 2–8°C, up to 28 days
Recommended solvent
Bacteriostatic water (0.9% benzyl alcohol) or 0.9% saline
Cold chain
2–8°C in transit · controlled thermal packaging
Use
Research Use Only (RUO). Not intended for human or veterinary use.
Typical values for this compound category. For batch-specific data, see the corresponding COA at /en/coa/.
🧪 Independent third-party analysis available — Janoshik Analytical (HPLC + MS).View all COAs →
This product is exclusively for research purposes. Not intended for human use, consumption, or therapeutic applications. For laboratory use only under qualified supervision.